MedTrace Logo

Effect of Oral Consumption of a Symbiotic Gelatin on the Presence of Gastrointestinal Symptoms and Quality of Life in People With Chronic Kidney Disease

NCT06745245 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2024-12-20

No results posted yet for this study

Summary

In patients with chronic kidney disease (CKD) there is a high prevalence of gastrointestinal disorders and negative changes in the microbiota and assimilation of nutrients, which is associated with an increased risk of morbidity and mortality.

Conditions

  • Chronic Kidney Disease(CKD)
  • Dysbiosis Symptoms Linked to Pathology
  • Probiotics Supplement

Interventions

DIETARY_SUPPLEMENT

Nutritional counseling and supplementation with a gelatin with prebiotic fiber and probiotic microorganisms

One serving (15 g) of symbiotic gelatin

Sponsors & Collaborators

  • Centro Medico Issemym

    collaborator OTHER

  • NIN Institute

    lead INDUSTRY

Principal Investigators

  • Paola Azucena Alvarado Pelayo, Bachelor · NIN Institute

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-12
Primary Completion
2025-09-12
Completion
2025-12-20

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06745245 on ClinicalTrials.gov